Peripheral Arterial Disease
Authors: Christine Laine
Journal: Annals of Internal Medicine (2007)

In the Clinic6 March 2007Peripheral Arterial DiseaseChristine Laine, MD, MPH, David R. Goldman, MD, and Jennifer F. WilsonChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, and Jennifer F. WilsonSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-146-5-200703060-01003 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The National Heart Lung and Blood Institute estimates that about 5% of U.S. adults older than 50 years of age and about 12% to 20% of adults older than 65 years have lower extremity atherosclerosis, commonly known as peripheral arterial disease (PAD). Despite the high prevalence, many patients and clinicians do not immediately consider PAD as a potential cause of leg pain in older people. The disease occurs equally in men and postmenopausal women, but men are more likely to have symptoms. Once recognized, modification of risk factors and therapeutic interventions can reduce PAD progression and improve symptoms and functional ...References1. Collins TC, Petersen NJ, Suarez-Almazor M, et al. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 2003;163:1469-74. [PMID: 12824097] Google Scholar2. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738-43. [PMID: 15262830] Google Scholar3. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961-5. [PMID: 12075249] Google Scholar4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957] Google Scholar5. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-53. [PMID: 9742976] Google Scholar6. Kallio M, Forsblom C, Groop PH, et al. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care. 2003;26:1241-5. [PMID: 12663604] Google Scholar7. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81. [PMID: 12020339] Google Scholar8. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol. 2004;24:e149-61. [PMID: 15297292] Google Scholar9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22. [PMID: 12114036] Google Scholar10. ACC/AHA 2005 Practice Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006 ACC/AHA 2005 practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). Circulation. 2006;113:1474-1547. (PMID: 16549652) Google Scholar11. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24. [PMID: 11560536] Google Scholar12. PAD Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6. [PMID: 1729621] Google Scholar13. McDermott MM, Fried L, Simonsick E, et al. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women’s health and aging study. Circulation. 2000;101:1007-12. [PMID: 10704168] Google Scholar14. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Surg. 2007;33:S1-S75. Google Scholar15. Brown OW, Bendick PJ, Bove PG, et al. Reliability of extracranial carotid artery duplex ultrasound scanning: value of vascular laboratory accreditation. J Vasc Surg. 2004;39:366-71; discussion 371. [PMID: 14743137] Google Scholar16. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA. 2001;285:1338-45. [PMID: 11255390] Google Scholar17. Pararajasingam R, Nasim A, Sutton C, et al. The role of screening blood tests in patients with arterial disease attending vascular outpatients. Eur J Vasc Endovasc Surg. 1998;16:513-6. [PMID: 9894492] Google Scholar18. Valentine RJ, Kaplan HS, Green R, et al. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg. 1996;23:53-61, discussion 61-3. [PMID: 8558743] Google Scholar19. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-8. [PMID: 9490235] Google Scholar20. Ouriel K, Green RM, DeWeese JA, et al. Activated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg. 1996;23:46-51, Discussion 51-2. [PMID: 8558741] Google Scholar21. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-296. [PMID: 10666287] Google Scholar22. Olin JW, Shih A. Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol. 2006;18:18-24. [PMID: 16344615] Google Scholar23. Gardner AW. The effect of cigarette smoking on exercise capacity in patients with intermittent claudication. Vasc Med. 1996;1:181-6. [PMID: 9546936] Google Scholar24. Willigendael EM, Teijink JA, Bartelink ML, et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg. 2005;42:67-74. [PMID: 16012454] Google Scholar25. Giswold ME, Landry GJ, Sexton GJ, et al. Modifiable patient factors are associated with reverse vein graft occlusion in the era of duplex scan surveillance. J Vasc Surg. 2003;37:47-53. [PMID: 12514577] Google Scholar26. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53. [PMIDD: 10639539] Google Scholar27. Stewart KJ, Hiatt WR, Regensteiner JG, et al. Exercise training for claudication. N Engl J Med. 2002;347:1941-51. [PMID: 12477945] Google Scholar28. Hiatt WR, Wolfel EE, Regensteiner JG, et al. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol. 1992;73:346-53. [PMID: 1506390] Google Scholar29. Hiatt WR, Regensteiner JG, Hargarten ME, et al. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602-9. [PMID: 2404633] Google Scholar30. McDermott MM, Liu K, Ferucci L, et al. Physical performance in peripheral arterial disease: a slower rate of decline in patienst who walk more. Ann Intern Med. 2006:144:10-20. Google Scholar31. Gardner AW, Katzel LI, Sorkin JD, Goldberg AP. Effects of long-term exercise rehabilitation on claudication distances in patients with peripheral arterial disease: a randomized controlled trial. J Cardiopulm Rehabil. 2002;22:192-8. [PMID: 12042688] Google Scholar32. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med. 2006;354:1706-17. (PMID: 16531616) Google Scholar33. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608-21. [PMID: 11372014] Google Scholar34. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg. 1998;27:267-74; discussion 274-5. [PMID: 9510281] Google Scholar35. Strandness DE Jr, Dalman RL, Panian S, et al. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002;36:83-91. [PMID: 11951094] Google Scholar36. Dawson DL, Cutler BS, Meissner MH, et al. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 1998;98:678-86. [PMID: 9715861] Google Scholar37. Ahimastos AA, Lawler A, Reid CM, et al. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med. 2006;144:660-4. [PMID: 16670135] Google Scholar38. Schürmann K, Mahnken A, Meyer J, et al. Long-term results 10 years after iliac arterial stent placement. Radiology. 2002;224:731-8. [PMID: 12202707] Google Scholar39. Surowiec SM, Davies MG, Eberly SW, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg. 2005;41:269-78. [PMID: 15768009] Google Scholar40. Feinglass J, Pearce WH, Martin GJ, et al. Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2001;34:283-90. [PMID: 11496281] Google Scholar41. O’Hare AM, Sidawy AN, Feinglass J, et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg. 2004;39:709-16. [PMID: 15071430] Google Scholar42. McDermott MM, Hahn EA, Greenland P, et al. Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med. 2002;17:895-904. [PMID: 12472925] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 6 March 2007Volume 146, Issue 5Page: ITC3-1KeywordsArteriesAtherosclerosisBlood pressureExerciseHypertensionMedical risk factorsPeripheral vascular diseaseRevascularizationWalking ePublished: 6 March 2007 Issue Published: 6 March 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...